Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

NCT01380145

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • New York University School of Medicine New York, United States
  • Mount Sinai Hospital New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

NCT02164955

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Cliniques Universitaires Saint Luc Brussels, Avenue Hippocrate 10, Belgium
  • Ziekenhuis Netwerk Antwerpen- Campus Middelheim Antwerp, Lindendreef 1, Belgium
  • Az Nikolaas Sint-Niklaas, Lodewijk de Meesterstraat 5, Belgium
  • Centre Hospitalier Peltzer-La Tourelle Verviers, Rue Du Parc 29, Belgium
View all 122 locations
View Trial Details
Completed

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

NCT01335399

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 1628 Birmingham, Alabama, United States
  • Local Institution - 7619 Mobile, Alabama, United States
  • Local Institution - 7618 Mobile, Alabama, United States
  • Local Institution - 7617 Chandler, Arizona, United States
View all 235 locations
View Trial Details
Completed

A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

NCT01677858

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Comprehensive Blood and Cancer Center (CCBC) Bakersfield, California, United States
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • Robert A. Moss, M.D., FACP, Inc. Fountain Valley, California, United States
View all 35 locations
View Trial Details
Completed

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

NCT02412878

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Research Site Bethesda, Maryland, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
View all 140 locations
View Trial Details
Completed

Multiple Myeloma Minimal Residual Disease

NCT02627261

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hôpital Huriez Lille, France
  • Centre Hospitalier Universitaire Hôtel-Dieu de Nantes Nantes, France
  • Centre Hospitalier Lyon Sud Pierre Bénité, France
View Trial Details

Related conditions